NDLI: Analysis of the survival of patients with hepatocellular carcinoma and indications for liver transplantation or hepatic resection

Content Provider	Springer Nature : BioMed Central
Author	Pinheiro, Rafael Soares Fonseca, Gilton Marques Andraus, Wellington Coelho, Fabricio Ferreira Rocha-Santos, Vinicius Pirola Kruger, Jaime Arthur Waisberg, Daniel R. Jeismann, Vagner de Martino, Rodrigo Bronze Ferrari Makdissi, Fabio Ducatti, Liliana Arantes Junior, Rubens Macedo Franca Bezerra, Regis Otaviano Rocha-Filho, Joel Avancini de Souza Rocha, Manoel Carneiro D’Albuquerque, Luiz Augusto Herman, Paulo
Abstract	Background Hepatic resection (HR) and liver transplantation (LT) are potentially curative treatments for Hepatocellular carcinoma (HCC). The aim of this study was to analyze the survival of patients with HCC and indications for surgical treatment (HR or LT) in a high-volume center. Methods This was a retrospective cohort study of consecutive patients with HCC and indications for LT or HR from May 2006 to July 2019. Analysis of overall survival (OS) and disease-free survival (DFS) rates, univariate analysis and construction of a multivariable model to identify risk factors were performed. Results A total of 744 patients with HCC were evaluated, 563 (75.6%) of whom were enrolled in waiting list for LT and 181 (24.4%) of whom underwent HR. Among the patients enrolled in the waiting list, 362 (64.3%) underwent LT, whereas 201 (35.7%) remained on the waiting list (WL). From the group of 201 patients on the waiting list, 97 (48.2%) were removed from the list due to tumor progression beyond the Milan criteria (MC), and 83 (41.3%) died while waiting for the transplant. In the WL group, 97 (48.2%) patients were removed from the list due to tumor progression beyond the MC, another 83 (41.3%) patients died while waiting for the LT. The OS rates of the LT group were 77.4%, 67.5% and 56.8%, whereas those of the WL + LT (intention-to-treat) group were 59.9%, 47.3%, and 39.9%, and the HRs were 82.8%, 49.3%, and 33.4% at 1, 5 and 10 years, respectively (p = 0.001). Donor age (p = 0.002) and cold ischemia time (p < 0.001) were independent factors related to OS in the LT group, whereas the presence of significant portal hypertension (p < 0.001), alpha-fetoprotein (AFP) value (p < 0.001) and MC (p = 0.002) were independent factors for HR. The DFS rates for HR were 74.9%, 40.0% and 31.0%, and those for LT were 97.9%, 92.0% and 90.9% at 1, 5 and 10 years, respectively (p < 0.001). Higher AFP levels were identified as an independent factor for lower DFS in both groups. Conclusions The present study revealed that the OS of patients listed for LT was greater in the first year than in the second year and that the results were similar to those of the HR in an intention-to-treat analysis. However, patients who achieve LT have better long-term outcomes, especially disease-free survival.
Related Links	https://bmcsurg.biomedcentral.com/counter/pdf/10.1186/s12893-025-02899-5.pdf
Ending Page	13
Page Count	13
Starting Page	1
File Format	HTM / HTML
ISSN	14712482
DOI	10.1186/s12893-025-02899-5
Journal	BMC Surgery
Issue Number	1
Volume Number	25
Language	English
Publisher	BioMed Central
Publisher Date	2025-04-18
Access Restriction	Open
Subject Keyword	Surgery Internal Medicine Carcinoma Hepatocellular Liver transplantation Hepatectomy Survival analysis Recurrence Liver cirrhosis
Content Type	Text
Resource Type	Article
Subject	Surgery
Journal Impact Factor	1.6/2023
5-Year Journal Impact Factor	1.9/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Hepatectomy for Early Hepatocellular Carcinoma: Not If, but When and How?

A Thoracoabdominal Hepatectomy and a Transdiaphragmatic Hepatectomy for Patients With Cirrhosis and Hepatocellular Carcinoma

Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma

Extended Hepatic Resection for Hepatocellular Carcinoma in Patients with Cirrhosis: Is It Justified?

Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy

Resection of hepatocellular carcinoma in patients with cirrhosis

Survival Benefits of Small Anatomical Resection of the Liver for Patients with Hepatocellular Carcinoma and Impaired Liver Function, Based on New-Era Imaging Studies.

Recent advances in hepatic resection and liver transplantation for hepatocellular carcinoma

Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching

Analysis of the survival of patients with hepatocellular carcinoma and indications for liver transplantation or hepatic resection

Similar Documents

Hepatectomy for Early Hepatocellular Carcinoma: Not If, but When and How?

A Thoracoabdominal Hepatectomy and a Transdiaphragmatic Hepatectomy for Patients With Cirrhosis and Hepatocellular Carcinoma

Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma

Extended Hepatic Resection for Hepatocellular Carcinoma in Patients with Cirrhosis: Is It Justified?

Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy

Resection of hepatocellular carcinoma in patients with cirrhosis

Survival Benefits of Small Anatomical Resection of the Liver for Patients with Hepatocellular Carcinoma and Impaired Liver Function, Based on New-Era Imaging Studies.

Recent advances in hepatic resection and liver transplantation for hepatocellular carcinoma

Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching

Analysis of the survival of patients with hepatocellular carcinoma and indications for liver transplantation or hepatic resection